Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 18;27(2):62. doi: 10.3892/ol.2023.14193

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Inoue et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 1. — Survival curves of CS-AZA1 and CLFS-AZA1 stratified according to disease risk and treatment intensity. (A) CS-AZA1 and (B) CLFS-AZA1 in the entire training set. (C) CS-AZA1 and (D) CLFS-AZA1 were stratified by the Revised International Prognostic Scoring System in the training set. RDI-AZA1 had no prognostic impact on (E) CS-AZA1 and (F) CLFS-AZA1. CS-AZA1, conditional survival period after the first cycle of azacitidine treatment; CLFS-AZA1, conditional leukemia-free survival period after the first cycle of azacitidine treatment; RDI-AZA1, relative dose intensity in the first cycle of azacitidine treatment.